Author

Yongfeng He

Weill Cornell Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Arshdeep SinghiD· 1 shared Dicle Özge Özgenel· 1 shared Geoffrey J. MarkowitziD· 1 shared Jeegar P. Patel· 1 shared Jonathan Villena‐VargasiD· 1 shared Liron YoffeiD· 1 shared Marissa M. MichaeliD· 1 shared Meixian Stephanie Tang· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Arshdeep SinghORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumor-draining lymph node derived CD8 T cells sustain durable systemic immunity after neoadjuvant IL-15 and PD-1 blockade

Tatiana Cruz, Rachel Honigsberg, Geoffrey J. Markowitz, Dicle Özge Özgenel, Arshdeep Singh, Meixian Stephanie Tang, Stella A. Martomo, Liron Yoffe, Yongfeng He, Yang Bai, Jeegar P. Patel, Marissa M. Michael, Mitchell T. Martin, Timothy E. McGraw, Olivier Elemento, , Jonathan Villena‐Vargas

Neoadjuvant IL-15 with PD-1 blockade expands lymph node clonal diversity and preserves stem-like CD8 T cell features, yielding superior antitumor efficacy, durable memory, and reduced metastatic recurrence.

bioRxiv · Aug 12, 2025 · PreprintImmunology